ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥..."/> ΪÁËÓëÆåÆå¹²¶ÈδÀ´£¬ÌÎÌÎÒãÈ»·ÅÆúÁ˾£ÖݵÄÊÂÒµ£¬×·ËæËýÀ´µ½ÁËÉîÛÚ¡£"/>

ÌÚ²©tengbo9885¹ÙÍø

ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...

ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...

¡¶ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...¡·¾çÇé¼ò½é£ºÎªÁËÓëÆåÆå¹²¶ÈδÀ´ÌÎÌÎÒãÈ»·ÅÆúÁ˾£ÖݵÄÊÂÒµ×·ËæËýÀ´µ½ÁËÉîÛÚ×ÏÎíÐý¼´ÏûÊŶ³öËûȬÓúµÄÉíÌåÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...·½Ô´ÊýÁËÊýÉÏÃæµÄʯ¶´ÂÔ΢¹ÀËãÁËÒ»ÏÂÖÁÉÙµÃÓÐÎå°ÙֻʯºïÕâÊÇËûÏÖÔÚΪֹÓöµ½µÄÊýÄ¿×î¶àµÄÒ»Ö»ºïȺµÚÈý½ÚÖжÎÕÅ×ÓÓîµÄ¾«²Êʩչһ¶È×ÊÖúÖйú¶Ó·´³¬Á˱ȷÖµ«ÃæÁÙÔ½·¢ÖÜÈ«µÄ°Ä´óÀûÑǶÓÖйú¶Ó×îÖÕÕÕ¾ÉÄÑÒÔ¶Ô¿¹ËûÃǵĹ¥ÊÆËäÈ»Õⳡ½ÇÖðÒÔʧÀûÁËÈ´µ«ÕÅ×ÓÓîµÄÌåÏÖÈÔÈ»ÈÃÈËÓ¡ÏóÉî¿ÌËýÕ¹ÏÖ³öÁËÖйúÀºÇòÔË·¢¶¯µÄ¼áÈÍºÍÆ´²«¾«ÉñΪÇòÃÔÃÇÁôÏÂÁËÉî¿ÌµÄÓ¡Ïó

¡¶ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...¡·ÊÓÆµËµÃ÷£º·×Æç»á¶ùһȺÈ˾͵½ÁËÄÚÔºÉî´¦´óÖü´æÊÒÖ®ÖÐÄÚÀï°Ú·ÅÁËÊýÊ®¸ö¿ÚÏä×ÓÕýºÃÊÇÒ»ÈËÒ»¿Ú¿ÉÊÇÄãÒÔΪËûÃÇÕæµÄÏñͯ»°¹ÊÊÂÒ»ÑùÐÒ¸£ÍêÂúÂðXÉÏÓиö½Ð@WuhanMemoryµÄÍøÓÑÖ±½Ó¿ªí¡£º-Îôʱ¾Í¿´³öÀ×¾ü¿¿×ìSU7ÕÕ¾ÉÀÏÎó²î-ÐÄÀíѧר¼ÒÕŽÌÊÚÓо仰˵µÃͦºÝ£º-һСÎÒ˽¼ÒÀÏʧԼ¹«ÖÚÔçÍí´ÓʧÍûÄð³ÉÄÕÅ­

Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix - PubMedTwitterFacebookLinkedInGitHubTwitterSM-FacebookSM-Youtube

±à¾ç£º
ÅÉçꡤÀÍÈð/
Ö÷ÑÝ£º
¶àÃ×Äá¿Ë¡¤ÄªÄɺº/ Â×¶Ø¡¤²¼ÀÊ/ ÀöÄ·¡¤Â¬°ÍÄá/ Î¬É­ÌØ¡¤ÅÁ˹ÍÐÀ×/ ¿­ÌØ¡¤¸£Ë¹ÌØ/
¸üУº

2025-10-05 21:16:58

±¸×¢£º
¹úÓï
ÆÀ¼Û£º
ÐüÒÉÆ¬¡¶ÐֵܵÄÅ®ÈË2Ãâ·ÑԢĿÕý°æµçÊӾ硷¸ßÇåµã²¥...

Ñ¡¼¯²¥·Å
ÅÅÐò

Ñ¡Ôñ²¥·ÅÔ´
¿ìËÙ²¥·Å¢Ù

Ïà¹ØÍÆ¼öTUIJIAN

ÂÞÍþÓï
¶¹°ê:5.6·Ö
¿ËÀï˹Íи¥¡¤ÂÞ±ö
ëÀûÓï
¶¹°ê:8.6·Ö
¾àÄãÒ»Ó¢Àï
ëÀûÓï
¶¹°ê:4.6·Ö
³µÔÚ‡å;
ÄϷǶ԰×
¶¹°ê:5.7·Ö
Ì츣ɽÆðÒå
ÄϷǶ԰×
¶¹°ê:6.4·Ö
ÆÆÀË
¶¹°ê:6.8·Ö
ħÎÝ1972
ëÀûÓï
¶¹°ê:3.7·Ö
µãµãÐǹâÓö¼ûÄã
Ó¡¶ÈÄáÎ÷ÑÇÓï
¶¹°ê:4.3·Ö
ÌðС½ãÓëÀäÏÈÉú
½Ý¿ËÓï
¶¹°ê:8.6·Ö
Цµ¯Ò»Âá¿ð
º«Óï¶Ô°×
¶¹°ê:8.4·Ö
×çÖä1988
ëÀûÓï
¶¹°ê:5.8·Ö
¹Å½£ÆæÌ·
Ó¢Óï¶Ô°×
¶¹°ê:4.5·Ö
»¨¿ªÓÐÉù2
ÆäËû
¶¹°ê:8.6·Ö
Ó¬Íõ1990
º«Óï¶Ô°×
¶¹°ê:4.5·Ö
ÍêÉÆµÛ¹ú
ÄϷǶ԰×
¶¹°ê:3.6·Ö
ϲÑòÑòÓë»ÒÌ«ÀÇÖ®¿ð³öδÀ´

ÕýÔÚÈÈÓ³

Ì©Óï¶Ô°× VideoZi
¶¹°ê:4.3·Ö
ƯÁÁÖ®ÂÃ
ÈÕÓï¶Ô°× VideoZi
¶¹°ê:6.8·Ö
°×ÒøµÛ¹ú
º«Óï¶Ô°× VideoZi
¶¹°ê:7.3·Ö
¼ÒÓÐϲÊÂ
º«Óï¶Ô°× VideoZi
¶¹°ê:8.7·Ö
Ò»¼ÒÁ½¿Ú
ÂÞÍþÓï VideoZi
¶¹°ê:7.5·Ö
ÎÞѪÎÞÀá
ÄÏ·Ç¶Ô°× VideoZi
¶¹°ê:4.8·Ö
°®¾¿¾¹
ëÀûÓï VideoZi
¶¹°ê:7.5·Ö
È«¶¼ÊÇÅݲË
ÆäËû VideoZi
¶¹°ê:6.4·Ö
¾ÅÏöÔÆÍâ
ÂÞÍþÓï VideoZi
¶¹°ê:6.4·Ö
ÅØÏøÎÞÉù
º«Óï¶Ô°× VideoZi
¶¹°ê:5.3·Ö
ÄÞºçµÆÏµÄÉÚ±ø
ÈÕÓï¶Ô°× VideoZi
¶¹°ê:3.5·Ö
·è¹·Óë¸ñÀ­ÈðС½ã
º«Óï¶Ô°× VideoZi
¶¹°ê:4.8·Ö
Ãþ½ðÖ®¹Å¹úÃØ¾³
VideoZi
¶¹°ê:4.5·Ö
ËĵÈСվ
ÂÞÍþÓï VideoZi
¶¹°ê:7.8·Ö
ÄãµÄ»ÄÔ­ÇóÉúÓ°Ï·°æ³öÌÓµÄÒ°ÊÞ
VideoZi
¶¹°ê:3.7·Ö
Ãþ½ðЦξ£¨Ï£©
¹úÓï¶Ô°× VideoZi
¶¹°ê:4.6·Ö
ǧÄê¿ÍÔÏ
ÂÞÍþÓï VideoZi
¶¹°ê:5.7·Ö
¶ñÁéÔÙÁÙ
º«Óï¶Ô°× VideoZi
¶¹°ê:7.6·Ö
Îą̊ɽ¿¹ÈÕ´«ÆæÖ®×ÔÁ¦Á¬
ÄÏ·Ç¶Ô°× VideoZi
¶¹°ê:8.3·Ö
Å®ÈËÏãÆø
Ó¢Óï¶Ô°× VideoZi
¶¹°ê:8.3·Ö
ÍõÅÆ¼ÌÐøÕß
Ê×Ò³
Ó°Ï·
Ò»Á¬¾ç
×ÛÒÕ
¶¯Âþ
APP
ÍøÕ¾µØÍ¼